The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin

Hadassah Medical Organization500 enrolled

Overview

We hypothesize that reduced dose of enoxaparin in elderly patients will result in reduced proportion of patients with therapeutic anti Xa activity and reduced clinical efficacy.

Patients treated with enoxaparin will be followed, sociodemographic , clinical and laboratory data will be collected. Clinical efficacy as well as adverse events will be monitored.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Acute Coronary Syndrome Venous Thromboembolism Atrial Fibrillation Hypercoagulability

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * treatment with enoxaparin Exclusion Criteria: * no

Locations (1)

Hadassah Medical Organization

Jerusalem, Israel

RECRUITING

Central Contacts

Mordechai Muszkat, MD

CONTACT

00-972-2-6776449 muszkatm@hadassah.org.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.